Upgrade to SI Premium - Free Trial

Acadia Pharmaceuticals (ACAD) PT Lowered to $17 at Oppenheimer

May 10, 2024 4:57 AM
(Updated - May 10, 2024 4:57 AM EDT)

Oppenheimer analyst Jay Olson lowered the price target on Acadia Pharmaceuticals ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles